Metronomic Temozolamide in Patients With Recurrent Glioblastoma
Clinical trial NCT01308632 · UNKNOWN
Trial details
- NCT number
- NCT01308632
- Sponsor
- Grupo Español de Investigación en Neurooncología
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2012-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.